RB

Ramesh Babu Konatham

Active Director Director DIN 08611809
DIN 08611809 First appointment Nov 2020 Primary industry Information Technology
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Nov 2020
Shareholding value •••• Premium profile

About Ramesh Babu Konatham

Data last updated:

Ramesh Babu Konatham is a Director at Experience Analytics India Private Limited (since 2022), Director at Ske Susruta Institute Of Medical Sciences Private Limited (since 2021) and Designated Partner at Eaar Consulting Llp (since 2022). The companies operate in Information Technology, Healthcare and Aviation. The 2 current companies with reported revenue have a combined latest revenue of ₹10.40 Cr; the largest is Experience Analytics India Private Limited at ₹7.02 Cr (FY 2025). Earlier, Ramesh Babu Konatham was a Director at Grtsa Technologies Private Limited (from 2020).

DIN 08611809
Primary Designation Director
Industry Information Technology
First Appointment 30 Nov 2020
Oldest Company Age 15 yrs
Largest company Experience Analytics India Private Limited · ₹7.02 Cr (FY 2025)
Combined revenue ₹10.40 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Nov 20222022₹7.02 Cr (FY 2025)Active
Director13 Apr 20212011₹3.38 Cr (FY 2025)Active
Designated Partner11 Oct 20222022Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Grtsa Technologies Private Limited U72900KA2019PTC130658
Director30 Nov 20202019₹1.46 Cr (FY 2024)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Grtsa Technologies Private Limited
Ske Susruta Institute Of Medical Sciences Private Limited
Eaar Consulting Llp
Experience Analytics India Private Limited
Premium access

Shareholding and investment profile for Ramesh Babu Konatham

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramesh Babu Konatham

Ramesh Babu Konatham currently holds 3 directorships: Experience Analytics India Private Limited (Director, since 10 Nov 2022, revenue ₹7.02 Cr (FY 2025)); Ske Susruta Institute Of Medical Sciences Private Limited (Director, since 13 Apr 2021, revenue ₹3.38 Cr (FY 2025)); Eaar Consulting Llp (Designated Partner, since 11 Oct 2022).

Ramesh Babu Konatham was first appointed on 30 Nov 2020 as Director at Grtsa Technologies Private Limited. The most recent appointment on record is 10 Nov 2022 at Experience Analytics India Private Limited.

The 2 current companies of Ramesh Babu Konatham that report revenue have a combined latest revenue of ₹10.40 Cr: Experience Analytics India Private Limited ₹7.02 Cr (FY 2025); Ske Susruta Institute Of Medical Sciences Private Limited ₹3.38 Cr (FY 2025).

Ramesh Babu Konatham held 1 earlier board appointment: Grtsa Technologies Private Limited (Director, from 30 Nov 2020).

The current boards of Ramesh Babu Konatham's companies include Anurag Dixit (Experience Analytics India Private Limited), Konatham Seshu Babu (Ske Susruta Institute Of Medical Sciences Private Limited), Krishnam Raju Penumetcha (Ske Susruta Institute Of Medical Sciences Private Limited), Pruthvi Raju Uppalapati (Ske Susruta Institute Of Medical Sciences Private Limited), Saragadam Kasi Eswara Apparao (Ske Susruta Institute Of Medical Sciences Private Limited), Sarojini Jonnalagadda (Ske Susruta Institute Of Medical Sciences Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available